* Drugmaker sells rights to Toprol-XL for up to $223 mln
(Adds sales forecasts, detail on Toprol-XL deal with Aralez)
The post UPDATE 1-AstraZeneca’s Brilinta drug fails in big arterial disease trial appeared first on NASDAQ.
Forex – financial instrument.Forex news
* Drugmaker sells rights to Toprol-XL for up to $223 mln
(Adds sales forecasts, detail on Toprol-XL deal with Aralez)
The post UPDATE 1-AstraZeneca’s Brilinta drug fails in big arterial disease trial appeared first on NASDAQ.